Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
Clinical trial NCT07441876 · RECRUITING
Trial details
- NCT number
- NCT07441876
- Sponsor
- BioMarin Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2029-06-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.